Anti-VEGF for Proliferative Sickle Cell Retinopathy
Clinical Minute RetinaAnti-VEGF for Proliferative Sickle Cell Retinopathy
Tailored Treatment in Retinal Disease: Using Biomarkers to Guide Anti-VEGF Therapy
Eye on Ocular HealthTailored Treatment in Retinal Disease: Using Biomarkers to Guide Anti-VEGF Therapy
Mapping the Landscape: Diagnostic Tools in Corneal Health
EmpowerMapping the Landscape: Diagnostic Tools in Corneal Health
- advertisement
Addressing Unmet Needs in Metastatic Uveal Melanoma
CME/CEAddressing Unmet Needs in Metastatic Uveal Melanoma
Second-Generation Biomarkers for Treatment Outcomes
MinuteCE®Second-Generation Biomarkers for Treatment Outcomes
Beyond Durability - What Biomarkers Reveal About Disease Control
MinuteCE®Beyond Durability - What Biomarkers Reveal About Disease Control
Macular Leakage: Indicator of Vascular Stability
MinuteCE®Macular Leakage: Indicator of Vascular Stability
Signs of Progress: PED as a Predictor of Disease and Outcomes
MinuteCE®Signs of Progress: PED as a Predictor of Disease and Outcomes
- advertisement
Managing Eye-Related Adverse Events Caused by Cancer Treatments
Medical Industry FeatureManaging Eye-Related Adverse Events Caused by Cancer Treatments
MIRASOL Insights in PROC: A Biomarker-Driven Approach
Project Oncology®MIRASOL Insights in PROC: A Biomarker-Driven Approach
The Importance of Diagnosing Dry Eye Disease Early
Medical Industry FeatureThe Importance of Diagnosing Dry Eye Disease Early
Inhibiting Inflammation in Dry Eye Disease
Medical Industry FeatureInhibiting Inflammation in Dry Eye Disease
Exploring Perspectives on Speed of Onset for Dry Eye Treatment
Medical Industry FeatureExploring Perspectives on Speed of Onset for Dry Eye Treatment
Patient Case Study: Targeting DED Inflammation
Medical Industry FeaturePatient Case Study: Targeting DED Inflammation
- 01/12/2026
- 01/09/2026
- 01/08/2026
- 01/07/2026
- 01/02/2026
- 12/24/2025

























































































